Royalty PharmaRPRX 
$28.21-0.11%24h
-0.11%24h
Global rank1303
Market cap$12.63B
Change 7d-1.98%
YTD Performance0.79%
SP500 benchmarkUnderperform
P/E11.15
P/S5.36
Revenue$2.35B
Earnings$1.70B
Dividend yield2.8%
Main Sector
Healthcare
EPS for Royalty Pharma (RPRX)
Royalty Pharma has an EPS of $2.53. In 2022, the company made an earnings per share (EPS) of $0.1. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for RPRX
-
Value:-
EPS history for Royalty Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $2.53 | 2430.00% |
| 2022 | $0.1 | -93.29% |
| 2021 | $1.49 | -40.69% |
| 2020 | $2.51 | - |
View the highest EPS stocks
